Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Okogen starts Phase II OKG-0301 trial for adenoviral conjunctivitis

Adenoviral conjunctivitis is one of the major causes of eye infections across the globe. Credit: scribbletaylor.



  • Okogen

Go Top